Vandetanib
|
|
443913-73-3
|
Motesanib
|
|
453562-69-1
|
Masitinib mesylate
|
|
1048007-93-7
|
Dasatinib hydrochloride
|
|
854001-07-3
|
Multi-kinase inhibitor 1
|
|
778274-97-8
|
Thalidomide
|
|
50-35-1
|
WEHI-345 analog
|
|
1354825-62-9
|
SU4312
|
|
5812-07-7
|
Acrizanib
|
|
1229453-99-9
|
MZP-54
|
|
2010159-47-2
|
PROTAC Mcl1 degrader-1
|
|
2163793-38-0
|
Lanraplenib succinate
|
|
1800047-00-0
|
PROTAC FAK degrader 1
|
|
2301916-69-6
|
ENMD-2076
|
|
934353-76-1
|
ARV-825
|
|
1818885-28-7
|
Ibrutinib-biotin
|
|
1599432-18-4
|
dTRIM24
|
|
2170695-14-2
|
ZXH-3-26
|
|
2243076-67-5
|
PAC
|
|
2158322-33-7
|
BSJ-03-123
|
|
2361493-16-3
|
PROTAC BRD4 ligand-1
|
|
2313230-51-0
|
Cereblon modulator 1
|
|
1860875-51-9
|
BSJ-04-132
|
|
2349356-39-2
|
Sunitinib Malate
|
|
341031-54-7
|
Ningetinib Tosylate
|
|
1394820-77-9
|
BMS-935177
|
|
1231889-53-4
|
BRD4 degrader AT1
|
|
2098836-45-2
|
PROTAC ERα Degrader-2
|
|
1351169-29-3
|
PROTAC BRD4 Degrader-5
|
|
2409538-70-9
|
SU14813 maleate
|
|
849643-15-8
|
Vorolanib
|
|
1013920-15-4
|
tBID
|
|
1639895-85-4
|
BI-4464
|
|
1227948-02-8
|
PF-573228
|
|
869288-64-2
|
SU16f
|
|
251356-45-3
|
Toceranib phosphate
|
|
874819-74-6
|
TG 100572 Hydrochloride
|
|
867331-64-4
|
Rogaratinib
|
|
1443530-05-9
|
Btk inhibitor 2
|
|
1558036-85-3
|
Rp-cAMPS sodium salt
|
|
142439-94-9
|
Vecabrutinib
|
|
1510829-06-7
|
dBET6
|
|
1950634-92-0
|
MS4078
|
|
2229036-62-6
|
XZ739
|
|
2365172-19-4
|
Lck inhibitor 2
|
|
944795-06-6
|
INDY
|
|
1169755-45-6
|
(±)-Zanubrutinib
|
|
1633350-06-7
|
SPP-86
|
|
1357349-91-7
|
AG 1295
|
|
71897-07-9
|
CNX-500
|
|
1202758-21-1
|
Nilotinib
|
|
641571-10-0
|
PF-06465469
|
|
1407966-77-1
|
CHMFL-BMX-078
|
|
1808288-51-8
|
TAK-659 hydrochloride
|
|
1952251-28-3
|
Ensartinib hydrochloride
|
|
2137030-98-7
|
THAL-SNS-032
|
|
2139287-33-3
|
Bosutinib
|
|
380843-75-4
|
PROTAC RIPK degrader-2
|
|
1801547-16-9
|
VZ185
|
|
2306193-61-1
|
SIAIS178
|
|
2376047-73-1
|
ARCC-4
|
|
1973403-00-7
|
PROTAC RIPK degrader-6
|
|
2089205-64-9
|
CP-10
|
|
2366268-80-4
|
Rp-cAMPS triethylammonium salt
|
|
151837-09-1
|
A-770041
|
|
869748-10-7
|
Tyrosine kinase inhibitor
|
|
1021950-26-4
|
Ibrutinib D5
|
|
1553977-17-5
|
Tirbanibulin Mesylate
|
|
1080645-95-9
|
MT-802
|
|
2231744-29-7
|
BI-3663
|
|
2341740-84-7
|
CSF1R-IN-1
|
|
2095849-04-8
|
PROTAC BET degrader-2
|
|
2093388-33-9
|
A1874
|
|
2064292-12-0
|
CDK9-IN-10
|
|
3542-63-0
|
BPR1K871
|
|
2443767-35-7
|
Navitoclax-piperazine
|
|
2143096-93-7
|
SJF620
|
|
2376187-16-3
|
KB02-JQ1
|
|
2384184-44-3
|
NV03
|
|
2448341-58-8
|
Tivozanib
|
|
475108-18-0
|
Dovitinib lactate
|
|
692737-80-7
|
KB SRC 4
|
|
1380088-03-8
|
Tyrosine kinase-IN-1
|
|
705946-27-6
|
Osteogenic Growth Peptide (10-14)
|
|
105250-85-9
|
BETd-246
|
|
2140289-17-2
|
MZP-55
|
|
2010159-48-3
|
PROTAC Bcl2 degrader-1
|
|
2378801-85-3
|
BSJ-03-204
|
|
2349356-09-6
|
Desmorpholinyl Navitoclax-NH-Me
|
|
2365172-82-1
|
Tirbanibulin dihydrochloride
|
|
1038395-65-1
|
3-Hydroxy Midostaurin
|
|
179237-49-1
|
PCI-33380
|
|
1022899-36-0
|
Conteltinib
|
|
1384860-29-0
|
N-piperidine Ibrutinib hydrochloride
|
|
2231747-18-3
|
PD173074
|
|
219580-11-7
|
SNIPER(BRD)-1
|
|
2095244-54-3
|
PROTAC FLT-3 degrader 1
|
|
2230826-81-8
|
Sunitinib
|
|
557795-19-4
|
Androgen receptor antagonist 1
|
|
1338812-36-4
|
PROTAC BET Degrader-10
|
|
1957234-97-7
|